Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Breakthrough Bleeding Unexpected spotting between periods can occur as hormone levels fluctuate
Continue reading More about tirzepatide Check interactions Compare alternatives Reviews (3,357) Latest FDA alerts (3) Side effects Dosage information During pregnancy Support group Drug class: GLP-1 Drugs Breastfeeding Patient resources Other brands Professional resources Other brands Related treatment guides Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Retatrutide is an experimental triple-agonist weight-loss and diabetes drug developed by Eli Lilly that targets GLP-1, GIP, and glucagon receptors
Tirzepatide is FDA-approved, making it both safe and effective in helping you attain significant weight loss results
CLA can be taken with meals to improve absorption, while L-Carnitine is effective when taken before workouts to optimize energy levels
What you need to know: Your doctor will check your potassium levels before starting treatment and regularly thereafter Normal potassium monitoring is typically every 3-6 months once stable You might need more frequent testing when starting either medication or changing doses 2
US$ 25.38
US$ 21.48
US$ 29.95
